IRCT20220607055095N2招募中2 期
pilot study of medium term effects of Trazodone and Atomoxetine combination on the number of apnea and apnea-hypopnea sleep index in obstructive sleep apnea patients
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 21 years 至 65 years(—)
- 性别
- All
入选标准
- •Definite diagnosis of obstructive sleep apnea with AHI>15 in polysomnography
- •lack of compliance treatment with CPAP or BIPAP
- •either the patient is unwilling to have surgery or they are not candidates for surgery in the opinion of the expert
排除标准
- •commodities' existence (excluding controlled blood pressure, hyperlipidemia and diabetes)
- •Taking any medication that leads to changes in the physiology of breathing, sleep / wake and muscles Taking any medication that leads to changes in the physiology of breathing, sleeping / waking and muscles
- •any underlying cardiac disease, such as arrhythmia
- •Inability to sleep in supine position
- •Hypersensitivity to lidocaine, atomoxetine or trazodone
- •History of seizures, Panic disorder, Hyperventilation syndrome, Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder
- •any hepatic disease or failure
研究者
相似试验
招募中
3 期
Evaluation of the effect of Trazodone in hospitalized patients with MSMS.Multiple sclerosisIRCT20210707051810N1Tehran University of Medical Sciences48
已完成
不适用
Long-term Study With Trazodone Once-a-DayMajor Depressive DisorderNCT04295941Aziende Chimiche Riunite Angelini Francesco S.p.A200
进行中(未招募)
不适用
DOSE-FINDING STUDY OF TRAZODONE IN THE TREATMENT OF PATIENTS WITH PRIMARY INSOMNIATREATMENT OF THE INSOMNIAMedDRA version: 6.1Level: PTClassification code 10022437EUCTR2005-002711-25-ITANGELINI160
进行中(未招募)
1 期
Study of Trazodone Once-a-Day for treatment of Depression in patients with breast cancer.Major Depressive DisorderEUCTR2021-005007-12-BGAngelini Pharma S.p.A.100
已完成
2 期
Trazodone in Painful Diabetic NeuropathyPainful Diabetic NeuropathyNCT03202979Aziende Chimiche Riunite Angelini Francesco S.p.A142
